Addressing Patient Concerns with Blood Transfusion from Donors Vaccinated Against COVID-19: A Clinician Primer-Reference-Cited by-同舟云学术

Addressing Patient Concerns with Blood Transfusion from Donors Vaccinated Against COVID-19: A Clinician Primer

Published:2024-03-08 Issue:5 Volume:140 Page:1020-1025
ISSN:0003-3022
Container-title:Anesthesiology
language:en
Short-container-title:

Author:

Forkin Katherine T.¹^ORCID,Guinn Nicole R.²,Warner Matthew A.³^ORCID,Panigrahi Anil K.⁴

Affiliation:

1. 1Department of Anesthesiology, University of Virginia Health, Charlottesville, Virginia.

2. 2Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.

3. 3Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.

4. 4Department of Anesthesiology and Pathology, Stanford University Medical Center, Stanford, California.

Abstract

Patient requests to avoid blood products from donors vaccinated against COVID-19 are on the rise. This primer provides the educational resources and tools for clinicians discussing these concerns with their patients, particularly in the perioperative period.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://pubs.asahq.org/anesthesiology/article-pdf/140/5/1020/703379/20240500.0-00028.pdf

Reference25 articles.

1. Association for the Advancement of Blood and Biotherapies, America’s Blood Centers, American Red Cross (January 2023). Joint statement: Blood community reiterates the safety of America’s blood supply for patients.Available at: www.aabb.org/docs/default-source/default-document-library/positions/joint-statement-blood-community-reiterates-the-safety-of-americas-blood-supply-for-patients.pdf?sfvrsn=c2fc3d52_10. Accessed December 27, 2023.

2. United States Food and Drug Administration (September 2023): Fatalities reported to FDA following blood collection and transfusion annual summary for FY2021.Available at: www.fda.gov/media/172382/download?attachment. Accessed 27 December 2023.

3. Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-year trends in prevalence, incidence, and residual risk, 2007 to 2016.;Dodd;Transfus Med Rev,2020

4. Re-examine the transfusion transmitted risk of SARS-CoV-2 virus during a major COVID-19 outbreak in 2022.;Ng;Transfus Med,2023

5. Risk of transfusion-transmitted infection with severe acute respiratory syndrome coronavirus 2 from blood donors in Japan.;Shinohara;Transfusion,2024